AMIVANTAMAB vs AMLODIPINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
AMIVANTAMAB vs AMLODIPINE: Safety Overview
| Metric | AMIVANTAMAB | AMLODIPINE |
|---|---|---|
| Total FAERS Reports | 748 | 64,924 |
| Deaths Reported | 116 | 10,161 |
| Death Rate | 15.5% | 15.7% |
| Hospitalizations | 445 | 26,787 |
| Average Patient Age | 63.5 yrs | 62.8 yrs |
| % Female Patients | 65.3% | 57.0% |
| FDA Approval Date | N/A | Apr 12, 2011 |
| Manufacturer | Janssen Biotech, Inc. | Teva Pharmaceuticals USA, Inc. |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | N/A | Prescription |